Arrowhead Pharmaceuticals, Inc. · NASDAQ:ARWR

BlackRock, Inc. reported a 13.80% stake in Arrowhead Pharmaceuticals, Inc. (Schedule 13G/A)

Event Mar 31, 2025 · Filed Apr 23, 2025

BlackRock, Inc. reported a 13.80% stake in Arrowhead Pharmaceuticals, Inc., 19,012,855 shares, as a passive investor on Mar 31, 2025. Filed Apr 23, 2025 (Schedule 13G/A).

Stake
13.80%
Shares
19,012,855
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BlackRock, Inc.13.80%19,012,855

Source

View original at SEC

Related